Search Grant Opportunities

Biology of Bladder Cancer (R21 Clinical Trial Optional)

ID: PAR-25-128 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Background
The National Cancer Institute (NCI) is issuing this Notice of Funding Opportunity (NOFO) to encourage applications that investigate the biology and underlying mechanisms of bladder cancer, a significant health problem in the United States and globally. Bladder cancer has a high incidence and frequent tumor recurrence, leading to a substantial medical burden. Despite recent advancements in molecular profiling and identification of mutated genes, there remains limited understanding of the molecular mechanisms driving bladder cancer initiation, progression, and malignancy. This NOFO aims to deepen knowledge of bladder cancer biology to aid in developing new interventions.

Grant Details
The grant supports exploratory/developmental research (R21) focused on novel scientific ideas or new model systems, tools, or technologies that could significantly impact biomedical research. Applications should investigate biological processes related to bladder cancer, including but not limited to:

- Understanding normal bladder development and differentiation;
- Examining mechanisms related to NMIBC prevention and progression;
- Studying the stromal environment's role in bladder cancer;
- Identifying functional drivers of NMIBC recurrence;
- Exploring biological mechanisms underlying disparities in bladder cancer;
- Developing new models that recapitulate the tumor microenvironment.

Projects must primarily focus on biological aspects of bladder cancer, although epidemiological or translational aims may complement the biological focus.

Eligibility Requirements
Eligible applicants include higher education institutions (public/state-controlled, private), nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), local/state/county governments, tribal governments, federal agencies, foreign organizations, and community-based organizations. Individuals from diverse backgrounds are encouraged to apply.

Period of Performance
The maximum project period for this grant is 2 years.

Grant Value
The combined budget for direct costs may not exceed $275,000 over the two-year project period, with no more than $200,000 requested in any single year.

Overview

Category of Funding
Education
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 11/19/24 the National Institutes of Health posted grant opportunity PAR-25-128 for Biology of Bladder Cancer (R21 Clinical Trial Optional) with funding of $200,000. The grant will be issued under grant program 93.393 Cancer Cause and Prevention Research.

Timing

Posted Date
Nov. 19, 2024, 12:00 a.m. EST
Closing Date
Sept. 7, 2025, 12:00 a.m. EDT Past Due
Last Updated
Nov. 20, 2024, 10:38 a.m. EST
Version
1
Archive Date
Oct. 13, 2025

Eligibility

Eligible Applicants
City or township governments
Native American tribal governments (Federally recognized)
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Independent school districts
For profit organizations other than small businesses
County governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$200,000
Floor
Not Listed
Estimated Program Funding
$200,000
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-25-128.html

Documents

Posted documents for PAR-25-128

Potential Applicants and Partners

Awardees that have recently won grants similar to PAR-25-128

Incumbent or Similar Grants

Grants similar to PAR-25-128

Similar Active Opportunities

Open grant opportunities similar to PAR-25-128